Trump set to nominate Texas cancer doctor to head FDA

Washington Post

25 October 2019 - If confirmed, Stephen Hahn would succeed acting commissioner Norman “Ned” Sharpless.

President Trump is poised to nominate Stephen Hahn, a top official at MD Anderson Cancer Center in Houston, to be the next commissioner of the FDA, according to people familiar with the situation. The announcement could come as soon as Thursday.

If confirmed, Hahn would head an agency that regulates a broad swath of the U.S. economy, including brand-name and generic drugs, medical devices, much of the nation’s food supply, and tobacco products.

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Management